Matthew Hoffmann

1.2k citations

39 papers · 519 indexed · h-index 13

Impact in

Hematology top 5%
- Multiple Myeloma Research and Treatments
Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria

Papers in ⓘ

Pharmacology 8
- Pharmacogenetics and Drug Metabolism 8
Hematology 10
- Multiple Myeloma Research and Treatments 7

Co-authors: Gondi Kumar (9 shared papers)Sekhar Surapaneni (10 shared papers)Claudia Kasserra (3 shared papers)Peter Schäfer (2 shared papers)Lori Capone (2 shared papers)William DeMaio (2 shared papers)Dawn Harper (1 shared paper)Rasmy Talaat (1 shared paper)
Journals: Xenobiotica (6 papers)Radiotherapy and Oncology (2 papers)Blood (2 papers)American Journal of Obstetrics and Gynecology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
Partner nations: United States Switzerland Australia

In The Last Decade

Matthew Hoffmann

38 papers receiving 493 citations

Peers

Countries citing papers authored by Matthew Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Matthew Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Hoffmann more than expected).

Fields of papers citing papers by Matthew Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Hoffmann. The network helps show where Matthew Hoffmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Hoffmann Line = papers co-authored together Matthew Hoffmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration Cancer Chemotherapy and Pharmacology ·Matthew Hoffmann, Claudia Kasserra, Josephine Reyes, Peter Schäfer, Jolanta Kosek, Lori Capone, Anastasia Parton, Heasook Kim‐Kang, Sekhar Surapaneni, Gondi Kumar	2012	98
2	Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects Drug Metabolism and Disposition ·Matthew Hoffmann, William DeMaio, Ronald A. Jordan, Rasmy Talaat, Dawn Harper, John Speth, JoAnn Scatina	2007	76
3	Disposition, metabolism and mass balance of [¹⁴C]apremilast following oral administration Xenobiotica ·Matthew Hoffmann, Gondi Kumar, Peter Schäfer, Dorota Cedzik, Lori Capone, K L Fong, Zhe-ming Gu, Dennis Heller, Hao Feng, Sekhar Surapaneni, Oscar L. Laskin, Anfan Wu	2011	41
4	Pomalidomide: Evaluation of cytochrome P450 and transporter-mediated drug-drug interaction potential in vitro and in healthy subjects The Journal of Clinical Pharmacology ·Claudia Kasserra, Mahmoud Assaf, Matthew Hoffmann, Yan Li, Liangang Liu, Xiaomin Wang, Gondi Kumar, Maria Palmisano	2014	31
5	Prodrugs of Perzinfotel with Improved Oral Bioavailability Journal of Medicinal Chemistry ·Reinhardt B Baudy, John A. Butera, Magid Abou‐Gharbia, Hong Chen, Boyd L. Harrison, Uday Jain, Ronald L. Magolda, Jean Y. Sze, Michael R. Brandt, Terri Cummons, Diane Kowal, Menelas N. Pangalos, Bojana Zupan, Matthew Hoffmann, Michael J. May, Cheryl P. Mugford, Jeffrey D. Kennedy, Wayne E. Childers	2009	27
6	Infections Requiring Hospitalization of Injection Drug Users Who Participated in an Injection Opiate Maintenance Program Clinical Infectious Diseases ·Stefano Bassetti, Matthew Hoffmann, Heiner C. Bucher, Ursula Flückiger, Manuel Battegay	2002	23
7	In vitro characterization of MOD‐5014, a novel long‐acting carboxy‐terminal peptide (CTP)‐modified activated FVII Haemophilia ·Ahuva Bar-Ilan, Tami Livnat, Matthew Hoffmann, Lior Binder, Miri Zakar, Rachel Guy, Yana Felikman, Laura Moschcovich, Elizabeth Shenkman, Dougald M. Monroe, Oren Hershkovitz, Gili Kenet, Gili Hart	2018	18
8	Recombinant activated factor VII and the anaesthetist Anaesthesia ·Ian J. Welsby, Dougald M. Monroe, Jeff Lawson, Matthew Hoffmann	2005	17
9	In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects The Journal of Clinical Pharmacology ·Yan Li, Liangang Liu, Xiaomin Wang, Chengyue Zhang, Josephine Reyes, Matthew Hoffmann, Maria Palmisano, Simon Zhou	2018	14
10	Absorption, distribution, metabolism and excretion of an isocitrate dehydrogenase-2 inhibitor enasidenib in rats and humans Xenobiotica ·Zeen Tong, Christian Atsriku, Usha Yerramilli, Xiaomin Wang, Yan Li, Josephine Reyes, Bin Fan, Hua Yang, Matthew Hoffmann, Sekhar Surapaneni	2018	13
11	Analysis of a volumetric-modulated arc therapy (VMAT) single phase prostate template as a class solution Reports of Practical Oncology & Radiotherapy ·Matthew Hoffmann, Jacqueline Pacey, Josie Goodworth, Andrea Laszcyzk, Richard Ford, Brendon Chick, Stuart Greenham, Justin Westhuyzen	2018	12
12	The Uremic Toxin Indoxyl-3-Sulfate Induces CYP1A2 In Primary Human Hepatocytes Drug Metabolism Letters ·Hong Liu, Rangaraj Narayanan, Matthew Hoffmann, Sekhar Surapaneni	2016	12
13	Embryo–fetal exposure and developmental outcome of thalidomide following oral and intravaginal administration to pregnant rabbits Reproductive Toxicology ·Julia Hui, Matthew Hoffmann, Gondi Kumar	2014	12
14	Implementation of an image guided intensity‐modulated protocol for post‐prostatectomy radiotherapy: Planning data and acute toxicity outcomes Journal of Medical Imaging and Radiation Oncology ·Benjamin Chua, Myo Min, Maree Wood, Sarah Edwards, Matthew Hoffmann, Stuart Greenham, Andrew Kovendy, Michael J. McKay, Thomas P. Shakespeare	2013	12
15	Modeling and Simulation to Probe the Pharmacokinetic Disposition of Pomalidomide R- and S-Enantiomers Journal of Pharmacology and Experimental Therapeutics ·Yan Li, Simon Zhou, Matthew Hoffmann, Gondi Kumar, Maria Palmisano	2014	11
16	Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimus Cancer Chemotherapy and Pharmacology ·Joseph Boni, Richat Abbas, Cathie Leister, Jaime Burns, Ronald A. Jordan, Matthew Hoffmann, William DeMaio, Bruce A. Hug	2008	11
17	Metaplastic carcinoma of the breast: Clinicopathological features and treatment outcomes with long‑term follow up Molecular and Clinical Oncology ·Aron Gortman, Noel J. Aherne, Justin Westhuyzen, Julan Amalaseelan, Patrick Dwyer, Matthew Hoffmann, Andrew Last, Thomas P. Shakespeare	2021	10
18	Application of a “Fit for Purpose” PBPK Model to Investigate the CYP3A4 Induction Potential of Enzalutamide Drug Metabolism Letters ·Rangaraj Narayanan, Matthew Hoffmann, Gondi Kumar, Sekhar Surapaneni	2016	9
19	Software-based evaluation of a class solution for prostate IMRT planning Reports of Practical Oncology & Radiotherapy ·Sarah Clarke, Josie Goodworth, Justin Westhuyzen, Brendan Chick, Matthew Hoffmann, Jacqueline Pacey, Stuart Greenham	2017	8
20	Synergistic Combination Activity of the Novel GSPT1 Degrader CC-90009 in Acute Myeloid Leukemia Models Blood ·Daniel W. Pierce, Tsun-Wen Sheena Yao, Emily Pace, Hongbin Wang, Pierre Flandin-Blety, Alicia Benitez, Carla Guarinós, Matthew Hoffmann, Soraya Carrancio, Jinhong Fan, Michael Pourdehnad	2021	7

About Matthew Hoffmann

Matthew Hoffmann is a scholar working on Pharmacology, Hematology, Radiation, Obstetrics and Gynecology and Genetics, having authored 39 papers that have together received 519 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Multiple Myeloma Research and Treatments (7 papers), Advanced Radiotherapy Techniques (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Radiation Dose and Imaging (4 papers), Cancer Treatment and Pharmacology (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Maternal and Perinatal Health Interventions (3 papers). The work is most often cited by research in Hematology (162 citations), Molecular Medicine (45 citations), Pharmacology (41 citations), Applied Microbiology and Biotechnology (9 citations) and Oncology (118 citations). Matthew Hoffmann has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Gondi Kumar, Sekhar Surapaneni, Claudia Kasserra, Peter Schäfer, Lori Capone, William DeMaio, Dawn Harper, Rasmy Talaat, John Speth and JoAnn Scatina. Their work appears in journals such as Xenobiotica, Radiotherapy and Oncology, Blood, American Journal of Obstetrics and Gynecology and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact